跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 57,538 条关于
“Section 3(d)”
全部
57,538
临床试验
32,653
药物
6,027
机构
3,747
资讯
15,111
5个月前
India's Section 3(d) and Compulsory Licensing: How Indian Patent Law Balances Innovation and Affordable Access to Life-Saving Medicines
去年
Delhi High Court Overturns Patent Rejection for Taiho Pharmaceutical's Anticancer Compound
去年
Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition
11天前
India Releases Draft 2026 Pharmaceutical Patent Examination Guidelines Rebuilding Examiner Toolkit Around a Decade of Case Law
7个月前
Indian Patent Office Rejects AbbVie's Venetoclax Patent Application, Opening Door for Generic Competition
4个月前
Indian Patent Office Rejects AbbVie Patents for Rinvoq and Maviret, Clearing Path for Generic Competition
4个月前
US Maintains Pressure on India's Pharmaceutical Patent System Through Priority Watch List Designation
5天前
Indian Patent Office Proposes Overhaul of Pharma and Biotech Patent Examination Guidelines
去年
India Maintains Firm Stance Against Patent Evergreening in Global Trade Negotiations
上个月
Delhi High Court Sets Aside Refusal of Array BioPharma's Cancer Drug Combination Patent, Orders Fresh Review
第 1 页,共 1512 页
上一页
下一页